MGV354
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MGV354, covering 2017-08-31 to 2017-08-31. Get the full timeline:
Most recent: Clinical Trial Update: A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma [Phase 1, Phase 2]